News & Press / August 27, 2024

Comagine Health Research and Evaluation Team Celebrates Conclusion of Long-Running Oregon HOPE Study

The Oregon HOPE study concluded in July after starting in 2017. The Research and Evaluation team’s work included developing a rural peer-based intervention from needs assessment data, surveys and interviews.

Congratulations to Comagine Health’s Research and Evaluation team, whose work on the long-running Oregon HOPE study concluded at the end of July.

The project, which began in 2017, included development of a rural peer-based intervention based on needs assessment data, in-depth surveys and interviews with people who use drugs and analysis of epidemiological data. Peers engaged people who use drugs through community outreach and syringe services, and people were provided hepatitis C/HIV testing, harm reduction tools and linkage to substance use disorder and hepatitis C treatment.

Comagine Health collaborated with Oregon Health & Science University, the Oregon Health Authority and community-based organizations. Funding was provided by The National Institute on Drug Abuse as part of the Rural Opioid Initiative research consortium. Current Comagine Health staff who contributed include Gillian Leichtling, Christi Hildebran, Erin Stack, Mary Gray, Sarah Soomin Shin, Kyn Kappesser and Sanae El Ibrahimi.

We celebrate everyone involved in the Oregon HOPE study for their efforts to make a difference for Oregonians! 

Media Contact